Fabrication of highly interconnected porous silk fibroin scaffolds for potential use as vascular grafts

Langer, 1993, Tissue engineering, Science, 260, 920, 10.1126/science.8493529

Smith, 2004, Nano-fibrous scaffolds for tissue engineering, Colloids Surf B Biointerfaces, 39, 125, 10.1016/j.colsurfb.2003.12.004

Garg, 2012, Scaffold: a novel carrier for cell and drug delivery, Crit Rev Ther Drug Carrier Syst, 29, 1, 10.1615/CritRevTherDrugCarrierSyst.v29.i1.10

Vepari, 2007, Silk as a biomaterial, Prog Polym Sci, 32, 991, 10.1016/j.progpolymsci.2007.05.013

Meinel, 2004, Engineering bone-like tissue in vitro using human bone marrow stem cells and silk scaffolds, J Biomed Mater Res A, 71A, 25, 10.1002/jbm.a.30117

Wang, 2006, Cartilage tissue engineering with silk scaffolds and human articular chondrocytes, Biomaterials, 27, 4434, 10.1016/j.biomaterials.2006.03.050

Altman, 2002, Silk matrix for tissue engineered anterior cruciate ligaments, Biomaterials, 23, 4131, 10.1016/S0142-9612(02)00156-4

Yang, 2007, Development and evaluation of silk fibroin-based nerve grafts used for peripheral nerve regeneration, Biomaterials, 28, 5526, 10.1016/j.biomaterials.2007.09.001

Zhang, 2008, In vitro evaluation of electrospun silk fibroin scaffolds for vascular cell growth, Biomaterials, 29, 2217, 10.1016/j.biomaterials.2008.01.022

Wharram, 2010, Electrospun silk material systems for wound healing, Macromol Biosci, 10, 246, 10.1002/mabi.200900274

Yan, 2012, Macro/microporous silk fibroin scaffolds with potential for articular cartilage and meniscus tissue engineering applications, Acta Biomater, 8, 289, 10.1016/j.actbio.2011.09.037

Kim, 2005, Three-dimensional aqueous-derived biomaterial scaffolds from silk fibroin, Biomaterials, 26, 2775, 10.1016/j.biomaterials.2004.07.044

Nazarov, 2004, Porous 3-D scaffolds from regenerated silk fibroin, Biomacromolecules, 5, 718, 10.1021/bm034327e

Tamada, 2005, New process to form a silk fibroin porous 3-D structure, Biomacromolecules, 6, 3100, 10.1021/bm050431f

Oliveira, 2012, Aligned silk-based 3-D architectures for contact guidance in tissue engineering, Acta Biomater, 8, 1530, 10.1016/j.actbio.2011.12.015

Ghosh, 2008, Direct-write assembly of microperiodic silk fibroin scaffolds for tissue engineering applications, Adv Funct Mater, 18, 1883, 10.1002/adfm.200800040

Ma, 2010, Polymer scaffolds for small-diameter vascular tissue engineering, Adv Funct Mater, 20, 2833, 10.1002/adfm.201000922

Hinrichs, 1997, Design of a new type of coating for the controlled release of heparin, J Control Release, 45, 163, 10.1016/S0168-3659(96)01571-4

Jin, 2005, Water-stable silk films with reduced β-sheet content, Adv Funct Mater, 15, 1241, 10.1002/adfm.200400405

Khang G, Lee SJ, Kim MS, Lee HB. Biomaterials: tissue engineering and scaffolds. Encyclopedia of Medical Devices and Instrumentation; 2006.

Mandal, 2009, Cell proliferation and migration in silk fibroin 3D scaffolds, Biomaterials, 30, 2956, 10.1016/j.biomaterials.2009.02.006

Cao, 2013, Facile fabrication of the porous three-dimensional regenerated silk fibroin scaffolds, Mater Sci Eng C Mater Biol Appl, 33, 3522, 10.1016/j.msec.2013.04.045

Cao, 2007, The preparation of regenerated silk fibroin microspheres, Soft Matter, 3, 910, 10.1039/b703139d

Chen, 2008, pH-triggered transition of silk fibroin from spherical micelles to nanofibrils in water, Macromol Res, 16, 539, 10.1007/BF03218556

Lee, 2009, Electrospinning of polysaccharides for regenerative medicine, Adv Drug Deliv Rev, 61, 1020, 10.1016/j.addr.2009.07.006

Clowes, 1977, Suppression by heparin of smooth muscle cell proliferation in injured arteries, Nature, 265, 625, 10.1038/265625a0

Darnell, 2013, Performance and biocompatibility of extremely tough alginate/polyacrylamide hydrogels, Biomaterials, 34, 8042, 10.1016/j.biomaterials.2013.06.061

Stewart, 2012, Inhibition of smooth muscle cell adhesion and proliferation on heparin-doped polypyrrole, Acta Biomater, 8, 194, 10.1016/j.actbio.2011.07.029

Yang, 2012, The role of heparin binding surfaces in the direction of endothelial and smooth muscle cell fate and re-endothelialization, Biomaterials, 33, 6615, 10.1016/j.biomaterials.2012.06.055

Savage, 2001, Antibodies against a putative heparin receptor slow cell proliferation and decrease MAPK activation in vascular smooth muscle cells, J Cell Physiol, 187, 283, 10.1002/jcp.1076

Blaukovitch, 2010, Heparin treatment of vascular smooth muscle cells results in the synthesis of the dual-specificity phosphatase MKP-1, J Cell Biochem, 110, 382, 10.1002/jcb.22543

Nillesen, 2007, Increased angiogenesis and blood vessel maturation in acellular collagen–heparin scaffolds containing both FGF2 and VEGF, Biomaterials, 28, 1123, 10.1016/j.biomaterials.2006.10.029

Nomi, 2002, Principals of neovascularization for tissue engineering, Mol Aspects Med, 23, 463, 10.1016/S0098-2997(02)00008-0

West, 2008, Vascularization of engineered tissues: approaches to promote angiogenesis in biomaterials, Curr Top Med Chem, 8, 300, 10.2174/156802608783790983

Jabbarzadeh, 2008, Induction of angiogenesis in tissue-engineered scaffolds designed for bone repair: a combined gene therapy–cell transplantation approach, Proc Natl Acad Sci USA, 105, 11099, 10.1073/pnas.0800069105

Lovett, 2009, Vascularization strategies for tissue engineering, Tissue Eng Part B Rev, 15, 353, 10.1089/ten.teb.2009.0085

Peters, 1998, Release from alginate enhances the biological activity of vascular endothelial growth factor, J Biomater Sci Polym Ed, 9, 1267, 10.1163/156856298X00389

Richardson, 2001, Polymeric system for dual growth factor delivery, Nat Biotechnol, 19, 1029, 10.1038/nbt1101-1029

Kaigler, 2006, VEGF scaffolds enhance angiogenesis and bone regeneration in irradiated osseous defects, J Bone Miner Res, 21, 735, 10.1359/jbmr.060120

Mao, 2009, Enhanced angiogenesis of porous collagen scaffolds by incorporation of TMC/DNA complexes encoding vascular endothelial growth factor, Acta Biomater, 5, 2983, 10.1016/j.actbio.2009.04.004

Janairo, 2012, Heparin-modified small-diameter nanofibrous vascular grafts, IEEE Trans NanoBioscience, 11, 22, 10.1109/TNB.2012.2188926

Kurpinski, 2010, The effect of fiber alignment and heparin coating on cell infiltration into nanofibrous PLLA scaffolds, Biomaterials, 31, 3536, 10.1016/j.biomaterials.2010.01.062

Pieper, 2002, Loading of collagen–heparan sulfate matrices with bFGF promotes angiogenesis and tissue generation in rats, J Biomed Mater Res, 62, 185, 10.1002/jbm.10267

Patel, 2004, Angiogenesis with biomaterial-based drug- and cell-delivery systems, J Biomater Sci Polym Ed, 15, 701, 10.1163/156856204774196117

Ashikari-Hada, 2005, Heparin regulates vascular endothelial growth factor 165-dependent mitogenic activity, tube formation, and its receptor phosphorylation of human endothelial cells. Comparison of the effects of heparin and modified heparins, J Biol Chem, 280, 31508, 10.1074/jbc.M414581200

Nishiguchi, 2010, Regulation of pathologic retinal angiogenesis in mice and inhibition of VEGF–VEGFR2 binding by soluble heparan sulfate, PLoS One, 5, e13493, 10.1371/journal.pone.0013493

Leijon, 2013, Attachment of flexible heparin chains to gelatin scaffolds improves endothelial cell infiltration, Tissue Eng Part A, 19, 1336, 10.1089/ten.tea.2011.0712

Ehrlich, 1988, Effects of heparin on vascularization of artificial skin grafts in rats, Exp Mol Pathol, 48, 244, 10.1016/0014-4800(88)90061-5

O’Brien, 2005, The effect of pore size on cell adhesion in collagen–GAG scaffolds, Biomaterials, 26, 433, 10.1016/j.biomaterials.2004.02.052